User profiles for Vincent Le Moing
 | Vincent Le MoingCHU de Montpellier Verified email at chu-montpellier.fr Cited by 11487 |
Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy
S Grabar, VL Moing, C Goujard, C Leport… - Annals of internal …, 2000 - acpjournals.org
Background: The prognostic value of discordant immunologic (CD4 cell increase) and
virologic (plasma HIV RNA level decrease) responses to antiretroviral treatment is not known. …
virologic (plasma HIV RNA level decrease) responses to antiretroviral treatment is not known. …
Prevention of infections during primary immunodeficiency
…, I Pellier, JL Stephan, V Le Moing… - Clinical infectious …, 2014 - academic.oup.com
Preventing infection during primary immunodeficiency (PID) can include antimicrobial agents,
immunotherapy, and immunization, depending on the type of PID. Observation is essential…
immunotherapy, and immunization, depending on the type of PID. Observation is essential…
Nrf2‐interacting nutrients and COVID‐19: time for research to develop adaptation strategies
There are large between‐ and within‐country variations in COVID‐19 death rates. Some very
low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have …
low death rate settings such as Eastern Asia, Central Europe, the Balkans and Africa have …
[HTML][HTML] Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases
J Bousquet, V Le Moing, H Blain, W Czarlewski… - World Allergy …, 2021 - Elsevier
COVID-19 is described in a clinical case involving a patient who proposed the hypothesis
that Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-interacting nutrients may help to prevent …
that Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)-interacting nutrients may help to prevent …
[HTML][HTML] Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3 …
…, O Launay, B Laviolle, V Le Moing… - The Lancet infectious …, 2022 - thelancet.com
Background The antiviral efficacy of remdesivir against SARS-CoV-2 is still controversial.
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
We aimed to evaluate the clinical efficacy of remdesivir plus standard of care compared with …
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study
…, P Rufat, N Boyer, P Renard, S Matheron, V Le Moing… - Hepatology, 2001 - Elsevier
In this study we analyzed the influence of human immunodeficiency virus (HIV) infection on
the course of chronic hepatitis C through multivariate analysis including age, alcohol …
the course of chronic hepatitis C through multivariate analysis including age, alcohol …
Changing profile of infective endocarditis: results of a 1-year survey in France
…, N Danchin, F Delahaye, J Etienne, V Le Moing… - Jama, 2002 - jamanetwork.com
ContextSince the first modern clinical description of infective endocarditis (IE) at the end of
the 19th century, the profile of the disease has evolved continuously, as highlighted in …
the 19th century, the profile of the disease has evolved continuously, as highlighted in …
Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey
C Selton-Suty, M Célard, V Le Moing… - Clinical infectious …, 2012 - academic.oup.com
Background. Observational studies showed that the profile of infective endocarditis (IE)
significantly changed over the past decades. However, most studies involved referral centers. We …
significantly changed over the past decades. However, most studies involved referral centers. We …
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
…, P Tattevin, D Garot, V Le Moing… - Proceedings of the …, 2021 - National Acad Sciences
The characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …
kinetics in hospitalized patients and its association with mortality is unknown. We analyzed …
Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial
…, I Ghout, D Simo, V Zeller, B Issartel, V Le Moing… - The Lancet, 2015 - thelancet.com
Background Duration of treatment for patients with vertebral osteomyelitis is mainly based
on expert recommendation rather than evidence. We aimed to establish whether 6 weeks of …
on expert recommendation rather than evidence. We aimed to establish whether 6 weeks of …